OCGN.MX Ocugen, Inc.
Company Analysis
Latest News
🔴 Ocugen is trading 5.88% down amid biotech and market pressure
Ocugen is trading at MXN 16.00, down 5.88%; macro and sector weakness are the likeliest context, with no confirmed company-specific catalyst. -...
🔴 Ocugen is trading 11% down
Ocugen is trading at MXN 16.96, down 10.74%, with no confirmed company-specific announcement explaining the October 12 decline. - Provided market context...
🔴 Ocugen is trading 11% down today; no confirmed company-specific catalyst
Ocugen is trading at MXN 16.96, with a change of -10.74% on October 9, 2026; no confirmed company-specific news directly explains the decline. - Ocugen is...
Ocugen's 8% Rally on Data Day: Can a Pre-Revenue Gene Therapy Firm Justify the Hype Before Results Hit the Podium
Shares of Ocugen jumped 8% to MXN 18.44 ahead of two clinical presentations scheduled today at The Retina Society's 59th Annual Scientific Meeting in Los...
🟢 Ocugen is trading 8% up today ahead of September 24 OCU410ST and OCU410 presentations
Ocugen is trading 8.03% up at MXN 18.44 as investors anticipate clinical presentations scheduled for September 24, 2026, at The Retina Society. - The company...
🟢 Ocugen is trading 7.97% up today ahead of OCU410ST Phase 1 data presentation
Ocugen is trading 7.97% higher at MXN 18.43, as its scheduled OCU410ST Phase 1 data presentation may be drawing attention. - Ocugen is scheduled to present...
🔴 Ocugen is trading 16.67% down today with immediate cause unclear
Ocugen is trading at MXN 20.00, down 16.67%, with the immediate cause unclear. - The scheduled Citi 2026 Biopharma Back to School Conference presentation is...
🔴 Ocugen is trading 8.33% down today with no clear company-specific catalyst
Ocugen is trading 8.33% down at MXN 22.00, with no clear company-specific catalyst reported for September 9, 2026. - Ocugen is scheduled to present at the...